Thermo Fisher and CSL form strategic partnership for biologics manufacturing in Lengnau

Thermo Fisher Scientific and CSL Limited entered a strategic partnership. Thermo Fisher will operate a new biologics manufacturing facility in Lengnau, Switzerland, under a long-term lease from CSL, with construction completion expected in mid-2021.

“Thermo Fisher will support CSL's product portfolio by leveraging its pharma services network, including drug product development, biologics manufacturing, sterile fill-finish, packaging and clinical trials logistics.”prnewswire.com

• 1 source
• prnewswire.comThermo Fisher Scientific and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma ServicesThermo Fisher ScientificMay 27, 2020

Summarized from public sources; check the original articles before acting on it.